A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies
Clinical trial NCT06388902 · SUSPENDED
Trial details
- NCT number
- NCT06388902
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-19
- Primary completion
- 2028-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.